Oppenheimer Asset Management’s Bio-Rad Laboratories Class A BIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $956K | Buy |
+3,431
| New | +$988K | 0.01% | 732 |
|
|
2025
Q4 | – | Sell |
-3,550
| Closed | -$995K | – | 1124 |
|
|
2025
Q3 | $995K | Buy |
3,550
+679
| +24% | +$185K | 0.01% | 753 |
|
|
2025
Q2 | $693K | Buy |
2,871
+54
| +2% | +$12.8K | 0.01% | 818 |
|
|
2025
Q1 | $686K | Buy |
2,817
+103
| +4% | +$31K | 0.01% | 794 |
|
|
2024
Q4 | $892K | Buy |
2,714
+45
| +2% | +$15.3K | 0.01% | 750 |
|
|
2024
Q3 | $893K | Sell |
2,669
-50
| -2% | -$15.9K | 0.01% | 747 |
|
|
2024
Q2 | $743K | Buy |
2,719
+446
| +20% | +$130K | 0.01% | 773 |
|
|
2024
Q1 | $786K | Sell |
2,273
-363
| -14% | -$119K | 0.01% | 741 |
|
|
2023
Q4 | $851K | Sell |
2,636
-661
| -20% | -$207K | 0.01% | 749 |
|
|
2023
Q3 | $1.18M | Hold |
3,297
| – | – | 0.02% | 646 |
|
|
2023
Q2 | $1.25M | Buy |
3,297
+673
| +26% | +$274K | 0.02% | 638 |
|
|
2023
Q1 | $1.26M | Buy |
2,624
+339
| +15% | +$159K | 0.02% | 618 |
|
|
2022
Q4 | $961K | Buy |
2,285
+757
| +50% | +$306K | 0.02% | 691 |
|
|
2022
Q3 | $638K | Buy |
1,528
+37
| +2% | +$18.4K | 0.01% | 776 |
|
|
2022
Q2 | $737K | Sell |
1,491
-23
| -2% | -$12K | 0.01% | 764 |
|
|
2022
Q1 | $853K | Sell |
1,514
-665
| -31% | -$401K | 0.01% | 786 |
|
|
2021
Q4 | $1.65M | Sell |
2,179
-482
| -18% | -$361K | 0.02% | 609 |
|
|
2021
Q3 | $1.98M | Buy |
2,661
+39
| +1% | +$29.2K | 0.03% | 538 |
|
|
2021
Q2 | $1.69M | Buy |
2,622
+29
| +1% | +$17.6K | 0.02% | 588 |
|
|
2021
Q1 | $1.48M | Buy |
2,593
+328
| +14% | +$194K | 0.02% | 606 |
|
|
2020
Q4 | $1.32M | Sell |
2,265
-15
| -0.7% | -$8.54K | 0.02% | 599 |
|
|
2020
Q3 | $1.18M | Sell |
2,280
-580
| -20% | -$294K | 0.02% | 569 |
|
|
2020
Q2 | $1.29M | Sell |
2,860
-146
| -5% | -$64.4K | 0.03% | 524 |
|
|
2020
Q1 | $1.05M | Sell |
3,006
-424
| -12% | -$156K | 0.03% | 533 |
|
|
2019
Q4 | $1.27M | Hold |
3,430
| – | – | 0.03% | 562 |
|
|
2019
Q3 | $1.14M | Sell |
3,430
-223
| -6% | -$72.7K | 0.03% | 573 |
|
|
2019
Q2 | $1.14M | Sell |
3,653
-73
| -2% | -$21.9K | 0.03% | 580 |
|
|
2019
Q1 | $1.14M | Buy |
3,726
+828
| +29% | +$223K | 0.03% | 572 |
|
|
2018
Q4 | $673K | Sell |
2,898
-549
| -16% | -$147K | 0.02% | 674 |
|
|
2018
Q3 | $1.08M | Buy |
3,447
+1,801
| +109% | +$559K | 0.02% | 597 |
|
|
2018
Q2 | $475K | Sell |
1,646
-48
| -3% | -$13.3K | 0.01% | 809 |
|
|
2018
Q1 | $424K | Sell |
1,694
-133
| -7% | -$33.9K | 0.01% | 830 |
|
|
2017
Q4 | $406K | Hold |
1,827
| – | – | 0.01% | 845 |
|
|
2017
Q3 | $406K | Sell |
1,827
-21
| -1% | -$4.73K | 0.01% | 849 |
|
|
2017
Q2 | $418K | Sell |
1,848
-303
| -14% | -$66K | 0.01% | 833 |
|
|
2017
Q1 | $428K | Buy |
+2,151
| New | +$414K | 0.01% | 829 |
|
Other funds holding BIO
VCM
VPM
AI
